Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
Journal of medical virology, 2018.
AT10_002S. pneumoniaebroadly neutralizing antibodiesinfluenza virusmurine modelMore(1+)
Treatment with anti-influenza antibody AT10_002 is associated with reduced weight loss, viral load, bacterial outgrowth and lung injury in a murine model of secondary pneumococcal pneumonia following influenza infection. This article is protected by copyright. All rights reserved.
Full Text (Upload PDF)
PPT (Upload PPT)